Integrating results across our tumor gene expression analysis and plasma/ascites lipidomics profiling studies provides support for a model of altered lipoprotein uptake in OC relative to benign tumors, mediated in part through the membrane receptor LSR (Fig. S7). Here, LSR is linked to benign neoplasm.